What is the expected growth rate of the cholesterol testing products market?
The global cholesterol testing products market is anticipated to grow at a CAGR of 8.3% from 2023 to 2030, reaching a size of USD 15.9 billion by the end of the forecast period. This growth is driven by factors such as increasing awareness of the health risks associated with high cholesterol, technological advancements in testing products, and the growing prevalence of lifestyle diseases.
Who are the key players in Cholesterol Testing Products Market?
Key players are Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories Inc., ACON Laboratories Inc., Lepu Medical Technology, SD BIOSENSOR INC., Ciga Healthcare, and SpectraCell Laboratories Inc.